Try searching for a player, team or fixture.
↑ ↓ navigate↵ open⌘K reopen
18+ · begambleaware.org · Past performance does not guarantee future results.
This site contains betting-related content intended for adults only. You must be 21 or older and physically located in a state where sports betting is legal to place a wager.
Chelsea's £61m winger takes meldonium case to CAS after FA keeps investigation shrouded in secrecy
Chelsea's £61m winger Mykhailo Mudryk has spent the past 18 months training at non-league Uxbridge FC while fighting a drugs ban that threatens to end his Premier League career. The 25-year-old Ukrainian, who tested positive for the banned substance meldonium, has now taken his case to the Court of Arbitration for Sport.
The stark contrast could not be more dramatic. A player who commanded one of the highest transfer fees in Premier League history now trains with hired goalkeepers at a ground where the average attendance is 300.
When Chelsea beat Arsenal to Mudryk's signature in January 2023, they were securing one of Europe's most coveted young talents. The initial €70m (£61m) fee reflected his status as a game-changing winger who had lit up the Champions League with Shakhtar Donetsk.
Now, instead of preparing for matches at Stamford Bridge, Mudryk keeps fit at Uxbridge FC's modest facilities with a private coach.
The numbers tell a devastating story:
Chelsea's investment ranks among the most expensive transfer disasters in football history. For context, Mudryk cost more than the entire playing budgets of most Championship clubs.
At 25, Mudryk should be entering his prime years. Instead, he has not played competitive football since a Conference League match against Heidenheim in November 2024.
I am in complete shock. I have never knowingly used any banned substances or broken any rules.
Those were Mudryk's only public words on the matter, released when his provisional suspension began in December 2024.
The BBC reports that Mudryk came into contact with meldonium while on international duty with Ukraine in October 2024. This timing raises critical questions about how a banned substance entered his system during a national team camp.
Meldonium is a cardiovascular medication that can increase respiratory capacity and stamina. The drug gained notoriety when tennis star Maria Sharapova received a two-year ban for testing positive in 2016.
Key facts about meldonium in sport:
The revelation that Mudryk encountered meldonium during international duty adds complexity to his case. Ukraine's medical staff would have been responsible for any treatments or supplements provided during that October 2024 camp.
This raises the possibility of contamination or medical error rather than deliberate doping. Such circumstances could be crucial in Mudryk's appeal to CAS.
The timeline of Mudryk's case reveals an unusually secretive process that has dragged on far longer than typical doping cases:
The FA has refused to disclose whether Mudryk is serving a full ban or remains on provisional suspension. This lack of transparency stands in stark contrast to other high-profile doping cases.
When Paul Pogba tested positive for DHEA in 2023, Juventus and Italian authorities were transparent about the process. His four-year ban was announced publicly and later reduced to 18 months on appeal.
The secrecy surrounding Mudryk's case has left Chelsea unable to plan, fans in the dark, and the player's reputation in limbo for 18 months.
Mudryk has hired Morgan Sports Law, the firm that successfully defended several high-profile athletes:
Their involvement suggests Mudryk's team believes there are strong grounds for appeal.
CAS has confirmed that both parties are "currently exchanging written submissions" with a hearing yet to be scheduled. The process could take several more months, potentially extending Mudryk's exile from football beyond two years.
For Chelsea, the situation remains a financial and sporting disaster. They cannot register a replacement while Mudryk remains contracted, yet they are paying wages to a player who may never play for them again. The club's £61m investment looks increasingly likely to become one of the most expensive write-offs in football history.
Mudryk's determination to return this year, evidenced by his training regime at Uxbridge, suggests he believes his CAS appeal will succeed. But even if he wins, the question remains whether a player can recover from two years out of elite football at such a crucial age.
Mudryk tested positive for meldonium, a banned substance, while on international duty with Ukraine in October 2024. He received a provisional suspension in December 2024 and is fighting the ban through the Court of Arbitration for Sport.
Mudryk has been training at non-league Uxbridge FC for 18 months with a private coach and hired goalkeepers. This is a stark contrast to his usual training at Chelsea's elite facilities.
Chelsea paid an initial £61m (€70m) to Shakhtar Donetsk for Mudryk in January 2023. Including wages, Chelsea's total investment is over £85m, making this one of football's most expensive transfer disasters.
Breaking NewsChelsea's £88.5 million investment in Mykhailo Mudryk has become one of football's most expensive disasters after the FA handed the Ukrainian winger a 4-year doping ban. The 23-year-old's suspension leaves Chelsea with a massive financial write-off and forces them into emergency January transfer mode.
The DugoutChelsea have placed Xabi Alonso on a three-man managerial shortlist despite Pochettino's recent improvements, continuing a destructive pattern that has seen five managers in two years. The potential appointment would trigger another tactical overhaul, disrupting transfer plans and squad development at a club that demands instant success while preventing any chance of achieving it.
Meldonium is a cardiovascular medication that can increase respiratory capacity and stamina. It has been banned by WADA since January 2016, with standard bans for first offences lasting four years, though these can be reduced in certain circumstances.
SportSignals is an independent publication. Views expressed are our own.
